Susan G. Komen for the Cure® Funds Breast Cancer Guidelines, Lung Cancer Guidelines Named in Honor and Memory of Dana Reeve
Release provided courtesy of National Comprehensive Cancer Network
WASHINGTON, D.C. — September 23, 2010 — Patients with cancer and their caregivers have a new resource to help them navigate the maze of treatment options that they often confront. Today at the NCCN Patient Advocacy Summit in Washington D.C., the National Comprehensive Cancer Network (NCCN) launched its new series of NCCN Guidelines for Patients™, consumer-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) outlining appropriate cancer treatment.
"The NCCN Clinical Practice Guidelines in Oncology are recognized by clinicians around the world as the standard for oncology care," said William T. McGivney, PhD, Chief Executive Officer, NCCN. "We are acutely aware of how important it is to provide the same timely, high-quality information to patients who need to understand their cancer treatment options and are thrilled to offer this unique and much needed resource."
The first two guidelines released cover breast and lung cancers. Susan G. Komen for the Cure® has provided the NCCN Foundation $160,000 in grant support to develop and distribute the NCCN Guidelines for Patients™: Breast Cancer.
"Women who are living with breast cancer today not only have to contend with the reality of their diagnosis, but also have to live in an increasingly complex and changing world. We understand now that breast cancer is not a single disease. You have to know the sub-type of the breast cancer, the stage of your disease and be able to evaluate the options available for you as an individual," said Diana Rowden, Survivorship and Outcomes Vice President at Susan G. Komen for the Cure®. "While there are a number of good resources available to these women, only the NCCN Guidelines for Patients™ provide the level of highly-specific, current information that patients want and need. We are very proud to take a leadership role in supporting these guidelines and making them available to breast cancer patients."
The NCCN Guidelines for Patients™: Lung Cancer is named in honor and memory of Dana Reeve, the wife of the late actor Christopher Reeve. Dana died of lung cancer in 2006, seven months after her diagnosis. Her sister, Deborah Morosini, MD, a member of the NCCN Foundation Board, has become an active spokesperson for increased awareness of lung cancer.
"When my sister, Dana, was diagnosed with lung cancer, I assumed, as a physician, that we would be able find the information we needed to sort through all the various treatment options,” said Deborah Morosini, MD. “It turned out to be much more difficult than I thought. These guidelines will fill a huge gap for patients and the people who are supporting them and will be an incredibly valuable tool in making them more knowledgeable partners in their own treatment. Losing my sister was a devastating experience for our whole family, but it is very meaningful to all of us to have these guidelines named in her honor and memory."
The NCCN Guidelines™ are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or “decision trees” that address every appropriate treatment option from initial work up throughout the course of the disease. The NCCN Guidelines for Patients™ translate these professional guidelines in a clear, step-by-step manner that patients can utilize as the basis for making decisions and discussing options with their physicians. By the end of 2010 or early 2011, NCCN anticipates releasing additional NCCN Guidelines for Patients™ for melanoma, non-Hodgkin's lymphomas (NHL), colon and prostate cancers, and ultimately plans on having patient versions for all major adult cancer sites.
The NCCN Guidelines for Patients™ are available at NCCN.com, which also features enhanced content for patients and caregivers. A link to the NCCN Guidelines for Patients™: Breast Cancer will also be available at komen.org. Additionally, NCCN is planning to develop hard copy versions of the NCCN Guidelines for Patients™.
The NCCN Guidelines for Patients™ program is the first major undertaking of the NCCN Foundation, formed in 2010 to support initiatives and research in patient education, survivorship and quality of life and to assist in developing the next generation of clinical expertise by providing opportunities for young clinicians, investigators, and nurses to participate in NCCN Guidelines Panels. The NCCN Foundation continues to seek philanthropic support for these efforts.
Melanoma survivor, ABC news anchor, and chair of the NCCN Foundation Board of Directors Sam Donaldson emphasized the ease of use of the NCCN Guidelines for Patients™ stating, “Rather than having to consult numerous sources, patients now have straightforward access to a wealth of information in a convenient, clearly-written format.”
To access the NCCN Guidelines for Patients™ free of charge, visit NCCN.com.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN. For more information, visit NCCN.org.